6th Oct 2011 11:59
Judges Scientific plc (the "Company")
6 October 2011
Director/PDMR Shareholding and Exercise of Options
The Company has today issued 3,000 new Ordinary Shares of 5p each in the Company ("Ordinary Shares") pursuant to the exercise of options under the Company's Approved Share Option Scheme. Application has been made for the new Ordinary Shares to be admitted to AIM and dealings are expected to commence on 13 October 2011.
Following the exercise of options, the enlarged issued share capital is 4,289,967 Ordinary Shares of 5p each.
The Company also announces that Ralph Cohen, a director of the Company, has today purchased 5,000 ordinary shares of 5p each in the Company ('Ordinary Shares') at 397p per Ordinary Share. He therefore has a beneficial interest in 15,000 Ordinary Shares representing 0.35% of the Company's issued Ordinary Share capital and total voting rights following the issue of shares referred to above.
Ralph also holds 52,083 Convertible Redeemable Shares of 1p each in the Company, representing 1.2% of the issued share capital of that class.
Enquiries:
Judges Scientific plc
David Cicurel, CEO
01342 323 600
Shore Capital
Pascal Keane
Edward Mansfield
020 7408 4090
Cardew Group
Melvyn Marckus
07775 896491
Related Shares:
Judges Scientific